Aslan Pharmaceuticals to Participate in 30th Annual Piper Jaffray Healthcare Conference
SINGAPORE, Nov. 20, 2018 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both […]